Advertisement

Reactions Weekly

, Volume 1736, Issue 1, pp 97–97 | Cite as

Edaravone

Anaphylactic reaction and hypersensitivity: case report
Case report
  • 14 Downloads

Reference

  1. Bower L, et al. Summary of the US safety data for Radicava (edaravone): Findings from the postmarketing pharmacovigilance. Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration 19 (Suppl. 1): 359 abstr. CMS-11, Jan 2018. Available from: URL: http://doi.org/10.1080/21678421.2018.1510583 [abstract] - USA

Copyright information

© Springer Nature Switzerland AG 2019

Personalised recommendations